{
  "documentMetadata": {
    "title": "Lyme Disease, Arthritis",
    "lastUpdated": "2024-07-12",
    "sourceFile": "Lyme Disease, Arthritis.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Arthritis occurs as a late manifestation of Lyme Disease.",
        "The reported frequency varies from <10% to up to 60% of untreated patients.",
        "Most commonly presents as monoarticular or oligo-articular arthritis of the knees.",
        "Synovial fluid: 500 to >100,000 cells/µL; neutrophil predominate.",
        "For details on diagnostic methods see: Lyme Disease, Diagnosis, and IDSA Lyme Disease Guidelines (Clin Infect Dis 72:e1, 2020)",
        "May be able to detect organism in joint fluid by PCR; although antibody tests are preferred method of diagnosis with PCR of joint fluid serving as confirmatory test when uncertain"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Borrelia burgdorferi"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "Adult"
        },
        "components": [
          {
            "drug": "Doxycycline",
            "dose": "100 mg",
            "route": "po",
            "frequency": "bid"
          }
        ],
        "durationDetail": {
          "fixedDuration": "28 days"
        }
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "Adult"
        },
        "components": [
          {
            "drug": "Amoxicillin",
            "dose": "500 mg",
            "route": "po",
            "frequency": "tid"
          }
        ],
        "durationDetail": {
          "fixedDuration": "28 days"
        }
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "Adult"
        },
        "components": [
          {
            "drug": "Cefuroxime axetil",
            "dose": "500 mg",
            "route": "po",
            "frequency": "bid"
          }
        ],
        "durationDetail": {
          "fixedDuration": "28 days"
        }
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "Pediatric"
        },
        "components": [
          {
            "drug": "Doxycycline",
            "dose": "4.4 mg/kg/day",
            "route": "po",
            "frequency": "divided bid"
          }
        ],
        "durationDetail": {
          "fixedDuration": "28 days"
        },
        "notes": "max 100 mg bid"
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "Pediatric"
        },
        "components": [
          {
            "drug": "Amoxicillin",
            "dose": "50 mg/kg/d",
            "route": "po",
            "frequency": "divided tid"
          }
        ],
        "durationDetail": {
          "fixedDuration": "28 days"
        }
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "Pediatric"
        },
        "components": [
          {
            "drug": "Cefuroxime axetil",
            "dose": "30 mg/kg/day",
            "route": "po",
            "frequency": "divided bid"
          }
        ],
        "durationDetail": {
          "fixedDuration": "28 days"
        },
        "notes": "Note: Cefuroxime susp not available in the US, may be available in other markets."
      }
    },
    {
      "type": "list",
      "items": [
        "Add NSAIDs for symptom relief",
        "If only partial response, treat for an additional 2 -4 weeks with IV therapy (Ceftriaxone preferred); if this fails, refer to rheumatologist"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "Adult"
        },
        "components": [
          {
            "drug": "Ceftriaxone",
            "dose": "2 gm",
            "route": "IV",
            "frequency": "q24h"
          }
        ],
        "durationDetail": {
          "fixedDuration": "14-28 days"
        }
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "Adult"
        },
        "components": [
          {
            "drug": "Penicillin G",
            "dose": "20-24 million units",
            "route": "IV/day"
          }
        ],
        "durationDetail": {
          "fixedDuration": "14-28 days"
        }
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "appliesTo": {
          "description": "Child (Age ≥ 8 yrs)"
        },
        "components": [
          {
            "drug": "Ceftriaxone",
            "dose": "50-75 mg/kg/d",
            "route": "IV"
          }
        ],
        "durationDetail": {
          "fixedDuration": "14-28 days"
        }
      }
    },
    {
      "type": "list",
      "items": [
        "If only partial response, treat for an additional 30 days"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Pediatrics: Doxycycline safe for up to 21 days regardless of age (AAP Red Book 2018, Section 4; J Pediatr 166:1246, 2015)."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Response to treatment of late Lyme Disease may require weeks to months for improvement.",
        "2020 Clinical practice guidelines (Neurology 96:262, 2021).",
        "Review: JAMA 315:1767 & 2461, 2016",
        "Summary: Med Lett 58:57, 2016"
      ]
    }
  ]
}
